March 2023 - Corcept Therapeutics

Genetically engineered human pituitary corticotroph tumor organoids exhibit divergent responses to glucocorticoid receptor modulators

March 28, 2023

Mallick et al • 2023 • Transl Res.

ROSELLA, GOG‑3073, ENGOT‑OV72/MITO: A Phase 3 Study of Relacorilant + Nab‑paclitaxel vs. Nab‑paclitaxel in Advanced, Platinum-resistant Ovarian Cancer

March 26, 2023

Alexander Olawaiye et al. • 2023 • SGO Annual Meeting 2023